Supplements-Volume6

System.String
    Volume 7, Supplement 1 (Mar 2016)suppid2
    Volume 7, Supplement 1 (Mar 2016)
    Volume 8, Supplement 1 (Jul/Aug 2017)

    Volume 7, Supplement 1 (Mar 2016)
    Volume 7, Supplement 2 (Nov/Dec 2016)

    Volume 7, Supplement 1 (Mar 2016)
    Volume 7, Supplement 1 (Mar 2016)

    Volume 7, Supplement 1 (Mar 2016)
    Volume 6, Supplement 1 (Mar/Apr 2015)

    Volume 7, Supplement 1 (Mar 2016)
    Volume 5, Supplement 1 (May/Jun 2014)

    Volume 7, Supplement 1 (Mar 2016)
    Volume 4, Supplement 1 (Nov/Dec 2013)

    Volume 7, Supplement 1 (Mar 2016)
    Volume 3, Supplement 1 (Nov/Dec 2012)

    Volume 7, Supplement 1 (Mar 2016)
    Volume 2, Supplement 2 (Sep/Oct 2011)

    Volume 7, Supplement 1 (Mar 2016)
    Volume 2, Supplement 1 (May/Jun 2011)

    JADPRO 1 Fig01

    Understanding the Role of Targets and Pathways in the Treatment of Non–Small Cell Lung Cancer

    A continuing education article for physicians, PAs, doctors of nursing practice, nurse practitioners, advanced practice nurses including clinical nurse specialists, and other advanced degree nurses.

    Click here for continuing education information.

    After reviewing the articles in this supplement, click on the "How to Earn Credit" page for instructions on how to take the learning assessment, complete the evaluation form, and earn credit.

    Annenberg Logo

    JADPRO Logo

    Logo Harborside Meded Color

     

    Faculty

    Lisa Cordes, PharmD, BCACP, BCOP, National Institutes of Health

    Sandra Cuellar, PharmD, BCOP, University of Illinois Hospital and Health Sciences System—Pharmacy Practice

    Marianne Davies, DNP, MSN, CNS, ACNP, AOCNP®, Yale University School of Nursing

    Beth Eaby-Sandy, MSN, CRNP, OCN®, Abramson Cancer Center, Hospital of the University of Pennsylvania

    Clell Hasenbank, PharmD, Providence St Mary Regional Cancer Center

    Karen Oishi, MSN, APRN, AGPCNP-BC, OCN®, The University of Texas MD Anderson Cancer Center

    Melinda Oliver, BA, BSN, RN, MPAP, The University of Texas MD Anderson Cancer Center

    Samantha Schmidt, PharmD, Lexington Medical Center

    Helen Shih, MSN, MPH, University of California, San Francisco Department of Thoracic Oncology

    Grashma Vadakkel, PharmD(c), University of South Florida College of Pharmacy

    Elizabeth S. Waxman, RN, MSN, AOCN®, ANP-BC, The University of Texas MD Anderson Cancer Center


    This supplement is supported by educational grants from the following companies: Genentech and Merck Sharp & Dohme Corp.

    Save


    3Cecredits

    Managing the Care of Patients With HER2-Positive Breast Cancer: A Collaborative Practice Model

    A continuing education article for physicians, PAs, doctors of nursing practice, nurse practitioners, advanced practice nurses including clinical nurse specialists, and other advanced degree nurses.

    Click here for continuing education information.

    After reviewing the articles in this supplement, click on the "How to Earn Credit" page for instructions on how to take the learning assessment, complete the evaluation form, and earn credit.

    JADPRO Logo

     

    Faculty

    Angela DeMichele, MD, MSCE, Alan and Jill Miller Endowed Chair in Breast Cancer Excellence and Professor of Medicine and Epidemiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA

    Jennie Greco Lattimer, MSN, BSN, CRNP, Oncology Nurse Practitioner, University of Pennsylvania Perelman Center for Advanced Medicine, Philadelphia, PA


    This supplement is supported by an educational grant from Genentech.


    3Cecredits

    The Advanced Practitioner's Guide to Multiple Myeloma

    A continuing education activity for nurse practitioners, physician assistants, clinical nurse specialists, advanced degree nurses, oncology and hematology nurses, pharmacists, and physicians.

    Click here for continuing education information.

    After reviewing the articles in this supplement, click on the "How to Earn Credit" page for instructions on how to take the learning assessment, complete the evaluation form, and earn credit.

    This CME/CE/CEU accredited supplement is jointly provided by

    IMF Logo

     

    Annenberg Logo

     

    JADPRO Logo

    This supplement has been developed by members of the International Myeloma Foundation Nurse Leadership Board

    Nurse Leadership Board Logo

     

    Faculty

    Page Bertolotti, RN, BSN, OCN, Samuel Oschin Cancer Center at Cedars-Sinai Medical Center

    Kevin Brigle, PhD, NP, VCUHS Massey Cancer Center

    Donna D. Catamero, ANP-BC, OCN, CCRC, Mount Sinai Medical Center

    Kathleen Colson, RN, BSN, BS, Dana-Farber Cancer Center

    Hollie Devine, MSN, ANP-BC, The Ohio State University Medical Center James Cancer Hospital

    Deborah Doss, RN, OCN, Dana-Farber Cancer Center

    Beth Faiman, PhD, MSN, APRN-BC, AOCN, Cleveland Clinic Taussig Cancer Institute

    Elizabeth Finley-Oliver, RN, BSN, OCN, H. Lee Moffitt Cancer Center and Research Institute

    Charise Gleason, MSN, NP-BC, AOCNP, Winship Cancer Institute of Emory University

    Sandra Kurtin, RN, MSN, AOCN, ANP-C, The University of Arizona Cancer Center

    Patricia A. Mangan, RN, MSN, APRN-BC, Abramson Cancer Center at the University of Pennsylvania

    Ali McBride, PharmD, MS, BCPS, BCOP, The University of Arizona Cancer Center

    Ann McNeill, RN, MSN, APN, John Theurer Cancer Center at HUMC

    Teresa Miceli, RN, BSN, OCN, Mayo Clinic-Rochester

    Kimberly Noonan, RN, ANP, AOCN, Dana-Farber Cancer Center

    Tiffany Richards, MS, ANP, AOCNP, MD Anderson Cancer Center

    Sandra Rome, RN, MN, AOCN, CNS, Cedars-Sinai Medical Center

    Joseph Tariman, PhD, ANP-BC, DePaul University

    Daniel Verina, BS, BSN, MSN, ACNP-BC, Mount Sinai Medical Center

    This supplement is provided by independent educational grants from the following companies: Takeda Oncology, Celgene Corporation, Binding Site, and Adaptive Biotechnologies.


     Jadpro 001 Fig01

    Methotrexate and Fluorouracil Toxicities:
    What Advanced Practitioners in Oncology Need to Know


    Faculty

    Christopher J. Campen, PharmD, BCPS, BCOP, Arizona Cancer Center, University of Arizona

    Wendy H. Vogel, MSN, FNP, AOCNP®, Wellmont Cancer Institute

    Julie M. Vose, MD, MBA, University of Nebraska Medical Center

    Continuing education credit is provided through the Meniscus Educational Institute, a triple accredited provider for CME/CE/CEU credits and contact hours, upon successful completion of the supplement and evaluation.

    This activity is supported by an unrestricted educational grant from BTG International.


    2Creditcontacthours

    Collaborative Practice Enhances Supportive Care in Cancer: Chemotherapy-Induced Nausea and Vomiting

    Faculty

    Rita Wickham, PhD, RN, AOCN®, Rush University College of Nursing (Adjunct Faculty)

    Sally Barbour, PharmD, BCOP, CPP, Duke University Medical Center

    Teresa Scardino, RPA-C, MPAS, Memorial Sloan Kettering Cancer Center

    Continuing education credit is provided through the Meniscus Educational Institute, a triple accredited provider for CME/CE/CEU credits and contact hours, upon successful completion of the supplement and evaluation.

    Supported by an unrestricted educational grant from Heron Therapeutics (formerly AP Pharma)


    Nursing Perspectives on Carfilzomib in Patients With Relapsed or Refractory Multiple Myeloma

    Guest Editor
    Sandra E. Kurtin, RN, MS, AOCN®, ANP-C

    The supplement and associated publication costs were funded by Onyx Pharmaceuticals, Inc. Fishawack Communications, Inc., provided medical writing and editorial assistance, supported by Onyx Pharmaceuticals.


    Monitoring, Treatment Resistance, and Treatment Failure in Chronic Myeloid Leukemia

    Breaking Barriers to Improved Outcomes

    Jorge Eduardo Cortes, MD
    The University of Texas MD Anderson Cancer Center
    Houston, Texas

    John M. Goldman, DM, FRCP, FRCPath, FMedSci
    Imperial College
    London, United Kingdom

    Timothy P. Hughes, MD, MBBS
    Centre for Cancer Biology
    Adelaide, Australia

    Faculty Perspectives by:

    Patricia S. Ault, RN, FNP, and Mary Beth Rios, CCRP, RN
    The University of Texas MD Anderson Cancer Center
    Houston, Texas

    CNE provided by MediCom Worldwide, Inc.

    This activity is supported by an unrestricted educational grant from ARIAD Pharmaceuticals, Inc.

     


    Proceedings of selected presentations from

    2nd Annual Managing Hematologic Malignancies: The Balancing Act

    Sandra Kurtin, RN, MS, AOCN®, ANP-C, University of Arizona and Arizona Cancer Center

    Jean A. Ridgeway, MSN, APN, NP-C, AOCN®, University of Chicago Medical Center

    Amy Goodrich, MSN, CRNP, John Hopkins Kimmel Cancer Center

    Elizabeth Bilotti, MSN, RN, APN, OCN®, John Theurer Cancer Center, Hackensack University Medical Center

    This activity is designed for oncology NPs, PAs, and CNSs interested in learning more about hematologic malignancies and the management of these patients.

    This supplement provides 1.5 contact hours of continuing education credit.

    This activity is jointly sponsored by Medical Education Resources, Inc., and Avid Education Partners, LLC.:

    MERlogo.gif                aep-logo-01cmyk.png

    Supported by educational grants from Celgene, Cephalon Oncology, and Millennium: The Takeda Oncology Company.

    Celgene.png         Cephalon.png    

    MLNM_Takeda_09cmyk.png


    Oral Mucositis: Addressing the Causes, Challenges, and Clinical Management

    Carrie F. Daly, MS, RN, AOCN®, Rush University Medical Center

    Annette M. Quinn, MSN, RN, University of Pittsburgh Medical Center

    Oral mucositis remains one of the most painful and debilitating side effects of cancer therapy. A working knowledge of the risk factors for oral mucositis and oral cavity assessment protocols is essential to early identification of signs and symptoms in high-risk patients. The use of evidence-based guidelines and patient education will facilitate symptom management and supportive care strategies designed to avoid reductions, delays, or discontinuation of cancer treatment.

    CE provided by:

    IMER-logo.jpg


Copyright © 2016 Harborside Press, LLC All rights reserved.                Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact
Copyright Notice/Disclaimer
Bot trap - Don't go here
click me